
    
      The biological being tested in this study is called darvadstrocel (Alofisel). This study is
      examining the long-term safety and efficacy of a repeat dose of Darvadstrocel in people who
      have Crohn's Disease and Complex Perianal Fistula.

      The study will enroll approximately 50 patients. Participants will be assigned to one
      treatment group to receive:

      â€¢ Darvadstrocel 120 million cells

      All participants would be allowed to receive one repeat dose of darvadstrocel in the whole
      study. This multi-center trial will be conducted worldwide. The overall time to participate
      in this study is approximately 3 years. Participants will make multiple visits to the clinic.
    
  